December 8, 2025 · Form 4 insider transaction
Ragosa Mark sold 42,841 shares of Kiniksa Pharmaceuticals Ltd. at $41.49 per share, a transaction worth $1.78M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.20 and $42.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.